What are the WIPO ST.25 requirements for nucleotide and amino acid sequence disclosures in patent applications?

WIPO ST.25 requirements for nucleotide and amino acid sequence disclosures in patent applications are outlined in MPEP 2422. These requirements are largely harmonized with USPTO requirements, but there are some key differences: WIPO ST.25 requires that nucleotide sequences containing fewer than 10 specifically defined nucleotides be included in the sequence listing. WIPO ST.25 requires that…

Read More

How does the validation function in WIPO Sequence work?

The validation function in WIPO Sequence is an integrated feature that helps users identify and correct errors in their sequence listing projects. As described in MPEP 2418: WIPO Sequence includes an integrated validation function that will alert users to most errors in a project or “Sequence Listing XML” data. The validation function generates a report…

Read More

What is the role of WIPO in processing priority claims for international design applications?

The World Intellectual Property Organization (WIPO) plays a crucial role in processing priority claims for international design applications: Priority claims are made in the international design application filed with WIPO. WIPO is responsible for initially processing and recording these priority claims. WIPO transmits the priority claim information to designated Contracting Parties, including the USPTO. According…

Read More

What is the significance of WIPO published applications under AIA 35 U.S.C. 102(a)(2)?

Under the America Invents Act (AIA), WIPO published applications that designate the United States are treated as U.S. patent application publications for prior art purposes. This is significant because: They are considered prior art regardless of their international filing date It doesn’t matter if they are published in English or not They are prior art…

Read More

How are WIPO published applications treated under AIA 35 U.S.C. 102(a)(2)?

Under the AIA, WIPO published applications that designate the United States are treated as U.S. patent application publications for prior art purposes. This treatment applies regardless of: The international filing date Whether they are published in English Whether the PCT international application enters the national stage in the United States The MPEP states: The WIPO…

Read More

How can I use the WIPO Digital Access Service (DAS) for priority documents in international design applications?

The WIPO Digital Access Service (DAS) can be used to facilitate the exchange of priority documents in international design applications. According to MPEP 2920.05(d): “Pursuant to Administrative Instruction 408, a priority claim made in accordance with Hague Agreement Rule 7(5)(c) may be accompanied by a WIPO Digital Access Service (DAS) access code, if available. The…

Read More

What are the requirements for a WIPO published application to be considered prior art under AIA 35 U.S.C. 102(a)(2)?

For a WIPO published application to be considered prior art under AIA 35 U.S.C. 102(a)(2), it must meet specific requirements. According to MPEP 2154.01(a): “AIA 35 U.S.C. 102(a)(2) sets forth three descriptions of U.S. patent documents that are available as prior art as of the date they were effectively filed with respect to the subject…

Read More